• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    EPA and DHA Omega-3 Ingredient Market

    ID: MRFR/F-B & N/36337-HCR
    128 Pages
    Sakshi Gupta
    October 2025

    EPA and DHA Omega-3 Ingredient Market Research Report By Source (Fish Oil, Algal Oil, Krill Oil, Flaxseed Oil, Chia Seed Oil), By Form (Liquid, Softgel, Powder, Capsule, Emulsion), By Application (Nutraceuticals, Food Beverages, Pharmaceuticals, Cosmetics, Animal Feed), By End Use (Human Health, Pet Care, Aquaculture, Infant Formulas, Functional Foods) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    EPA and DHA Omega-3 Ingredient Market Infographic
    Purchase Options

    EPA and DHA Omega-3 Ingredient Market Summary

    As per MRFR analysis, the EPA and DHA Omega-3 Ingredient Market was estimated at 3.821 USD Billion in 2024. The EPA and DHA Omega-3 industry is projected to grow from 4.025 USD Billion in 2025 to 6.767 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.33 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The EPA and DHA Omega-3 Ingredient Market is experiencing robust growth driven by health trends and innovation.

    • North America remains the largest market for EPA and DHA Omega-3 ingredients, reflecting a strong consumer focus on health and wellness.
    • The Asia-Pacific region is emerging as the fastest-growing market, driven by increasing health consciousness and dietary shifts.
    • Fish oil continues to dominate the market, while algal oil is rapidly gaining traction as a plant-based alternative.
    • Key market drivers include the rising demand for nutritional supplements and growing awareness of the health benefits associated with Omega-3 fatty acids.

    Market Size & Forecast

    2024 Market Size 3.821 (USD Billion)
    2035 Market Size 6.767 (USD Billion)
    CAGR (2025 - 2035) 5.33%

    Major Players

    DSM Nutritional Products (CH), BASF SE (DE), Cargill, Incorporated (US), Omega Protein Corporation (US), Martek Biosciences Corporation (US), Aker BioMarine (NO), Epax AS (NO), Kewpie Corporation (JP), FMC Corporation (US)

    EPA and DHA Omega-3 Ingredient Market Trends

    The EPA and DHA Omega-3 Ingredient Market is currently experiencing a notable transformation, driven by increasing consumer awareness regarding health benefits associated with omega-3 fatty acids. These essential nutrients, primarily found in fish oil and algae, are recognized for their potential to support cardiovascular health, cognitive function, and overall well-being. As a result, there is a growing demand for dietary supplements and functional foods enriched with EPA and DHA. This trend is further fueled by the rising prevalence of lifestyle-related health issues, prompting consumers to seek preventive measures through nutrition. Moreover, the market landscape is evolving with advancements in extraction and processing technologies, which enhance the quality and bioavailability of omega-3 ingredients. Innovations in product formulations are also emerging, catering to diverse dietary preferences, including vegan and vegetarian options. This diversification appears to attract a broader consumer base, thereby expanding market reach. Additionally, regulatory support and favorable policies from various governments may contribute to the growth of the EPA and DHA Omega-3 Ingredient Market, as they promote the incorporation of these beneficial ingredients into food products. Overall, the market seems poised for continued expansion as awareness and accessibility increase.

    Rising Health Consciousness

    There is a discernible shift towards health-conscious living among consumers, leading to heightened interest in omega-3 fatty acids. This trend is characterized by an increasing preference for dietary supplements and functional foods that incorporate EPA and DHA, as individuals seek to enhance their overall health and prevent chronic diseases.

    Technological Advancements in Extraction

    Innovations in extraction and processing technologies are significantly impacting the EPA and DHA Omega-3 Ingredient Market. These advancements not only improve the quality and purity of omega-3 ingredients but also enhance their bioavailability, making them more effective for consumers.

    Diverse Product Offerings

    The market is witnessing a diversification of product offerings, catering to various dietary preferences. With the rise of veganism and vegetarianism, manufacturers are developing plant-based sources of EPA and DHA, thereby appealing to a broader audience and expanding market opportunities.

    The increasing recognition of the health benefits associated with EPA and DHA Omega-3 fatty acids is likely to drive consumer demand, particularly in dietary supplements and functional foods.

    U.S. Food and Drug Administration (FDA)

    EPA and DHA Omega-3 Ingredient Market Drivers

    Growing Awareness of Omega-3 Benefits

    The benefits of EPA and DHA Omega-3 ingredients are becoming more widely recognized, contributing to their growing popularity in the market. Research indicates that these fatty acids play a crucial role in reducing inflammation, improving heart health, and enhancing brain function. As scientific studies continue to validate these health claims, consumers are more inclined to incorporate EPA and DHA Omega-3 ingredients into their diets. The EPA and DHA Omega-3 Ingredient Market is responding to this trend by developing innovative products that highlight these benefits, such as omega-3 fortified foods and dietary supplements. This increased awareness is not only driving sales but also encouraging manufacturers to invest in marketing strategies that educate consumers about the advantages of omega-3 consumption. Consequently, the market is likely to expand as more individuals seek to improve their health through the inclusion of these essential nutrients.

    Regulatory Support for Omega-3 Products

    Regulatory bodies are increasingly recognizing the importance of EPA and DHA Omega-3 ingredients, leading to supportive policies that facilitate market growth. Governments are promoting the consumption of omega-3 fatty acids due to their health benefits, which has resulted in favorable regulations for manufacturers. This support is evident in various countries where guidelines encourage the fortification of food products with EPA and DHA Omega-3 ingredients. The EPA and DHA Omega-3 Ingredient Market benefits from this regulatory environment, as it fosters innovation and encourages companies to develop new products that meet consumer demand. Additionally, the establishment of safety and quality standards enhances consumer trust, further driving market expansion. As regulations continue to evolve, the market is expected to witness increased investment and product development, ultimately benefiting consumers seeking high-quality omega-3 options.

    Increasing Demand for Nutritional Supplements

    The rising awareness regarding health and wellness has led to an increasing demand for nutritional supplements, particularly those containing EPA and DHA Omega-3 ingredients. Consumers are becoming more proactive about their health, seeking products that support cardiovascular health, cognitive function, and overall well-being. The EPA and DHA Omega-3 Ingredient Market is experiencing a notable surge, with the market projected to reach USD 5 billion by 2026. This growth is driven by the aging population and the prevalence of chronic diseases, which has prompted individuals to seek preventive health measures. Furthermore, the incorporation of these ingredients into various products, such as functional foods and beverages, is expanding the market reach, appealing to a broader audience. As consumers increasingly prioritize health, the demand for EPA and DHA Omega-3 ingredients is likely to continue its upward trajectory.

    Technological Innovations in Omega-3 Production

    Technological advancements in the extraction and production of EPA and DHA Omega-3 ingredients are transforming the market landscape. Innovations such as supercritical CO2 extraction and enzymatic processing are enhancing the efficiency and purity of omega-3 products. These technologies not only improve yield but also ensure that the final products retain their nutritional integrity. The EPA and DHA Omega-3 Ingredient Market is witnessing a shift towards more sustainable production methods, which appeal to environmentally conscious consumers. As manufacturers adopt these cutting-edge technologies, they are better positioned to meet the growing demand for high-quality omega-3 ingredients. This focus on innovation is likely to drive competition within the market, leading to a wider array of products and potentially lower prices for consumers.

    Rising Popularity of Plant-Based Omega-3 Sources

    The trend towards plant-based diets is influencing the EPA and DHA Omega-3 Ingredient Market, as consumers seek alternative sources of omega-3 fatty acids. Algal oil, a plant-based source of EPA and DHA, is gaining traction among vegetarians and vegans who are looking for sustainable and ethical options. This shift is prompting manufacturers to explore innovative extraction methods and product formulations that cater to this demographic. The market for plant-based omega-3 ingredients is projected to grow significantly, with estimates suggesting a compound annual growth rate of over 10% in the coming years. As more consumers adopt plant-based lifestyles, the demand for EPA and DHA Omega-3 ingredients derived from algae is likely to increase, driving market diversification and expansion.

    Market Segment Insights

    By Source: Fish Oil (Largest) vs. Algal Oil (Fastest-Growing)

    In the EPA and DHA Omega-3 Ingredient Market, the segmentation by source reveals a diverse mix of products. Fish oil remains the largest contributor, driven by its long-standing acceptance in dietary supplements and fortified foods. Algal oil, on the other hand, is gaining traction due to increasing veganism and demand for plant-based alternatives. The presence of krill oil, flaxseed oil, and chia seed oil further enriches the market, each catering to niche consumer segments. These sources collectively provide a broad spectrum of options for consumers looking to boost their Omega-3 intake.

    Fish Oil (Dominant) vs. Algal Oil (Emerging)

    Fish oil is regarded as the dominant source of EPA and DHA Omega-3s due to its extensive approval by health professionals and the public. It is traditionally derived from oily fish, making it rich in these essential fatty acids, which are critical for cardiovascular health. On the other hand, algal oil is emerging as a strong contender in the market, appealing particularly to those seeking plant-based options. Rich in DHA, algal oil is gaining popularity not only among vegans and vegetarians but also among environmentally-conscious consumers. The rise of this segment is driven by an increasing awareness of sustainability issues, creating potential for further expansion.

    By Form: Liquid (Largest) vs. Softgel (Fastest-Growing)

    In the EPA and DHA Omega-3 Ingredient Market, the segment distribution is notable, with Liquid forms holding a significant share, making them the largest category. Softgels, on the other hand, are rapidly gaining traction among consumers, preferring the convenience and palatability of this form. Further segments like Powder, Capsule, and Emulsion also contribute to market diversity but remain behind in market share, with Liquid and Softgel taking the lead.

    Liquid (Dominant) vs. Softgel (Emerging)

    Liquid EPA and DHA Omega-3 ingredients dominate the market due to their versatility and ease of consumption, appealing to a broad range of consumers like health-conscious individuals and athletes. Their formulation allows for greater bioavailability, ensuring effective absorption. Conversely, Softgel formats are emerging as a favored choice, particularly among those seeking convenience in their dietary supplements. As the trend towards personalized nutrition grows, Softgels provide a user-friendly option, favored by those averse to the taste of oils. The increasing preference for Softgels highlights a shift in consumer behavior, making them a vital player in the evolving Omega-3 landscape.

    By Application: Nutraceuticals (Largest) vs. Pharmaceuticals (Fastest-Growing)

    The EPA and DHA Omega-3 ingredient market showcases diverse applications, with nutraceuticals being the largest segment. This segment dominates as consumers increasingly incorporate omega-3 supplements into their health and wellness routines, driven by awareness of their numerous benefits. Pharmaceuticals are emerging as a significant segment as well, thanks to the growing development of omega-3-based drugs for cardiac health and mental wellbeing, making them one of the fastest-growing areas in this market.

    Nutraceuticals: Dominant vs. Pharmaceuticals: Emerging

    Nutraceuticals represent a dominant force in the EPA and DHA Omega-3 ingredient market, providing a multitude of supplements that cater to health-conscious consumers. With an array of products—ranging from capsules to liquid formats—this segment benefits from a strong consumer shift towards preventive healthcare. On the other hand, pharmaceuticals, while emerging, leverage significant scientific research, leading to innovations in omega-3 applications for treating specific health issues. The growing prescription of omega-3 for chronic diseases such as heart conditions highlights their anticipated impact in the healthcare sector, ultimately driving demand in this segment.

    By End-Use: Human Health (Largest) vs. Aquaculture (Fastest-Growing)

    In the EPA and DHA Omega-3 Ingredient Market, the distribution of market share among the end-use segments reveals Human Health as the largest segment, driven by increasing consumer awareness regarding the benefits of omega-3 fatty acids for cardiovascular health and overall wellness. Following closely, the Pet Care segment demonstrates significant contributions to market dynamics, while the Aquaculture segment is rapidly gaining traction as sustainable fish farming practices rise. Meanwhile, Infant Formulas and Functional Foods also play critical roles in the market's ecosystem, catering to specific health needs and dietary preferences.

    Human Health: Dominant vs. Aquaculture: Emerging

    The Human Health segment stands out as the dominant force within the EPA and DHA Omega-3 Ingredient Market, capitalizing on the rising trend of health-conscious living and preventive healthcare measures. Consumers increasingly prioritize omega-3-rich diets, seeking out supplements and fortified foods to enhance health outcomes. In contrast, the Aquaculture segment is emerging as a key player, benefiting from the demand for sustainable seafood and eco-friendly farming practices. Innovations in aquaculture methods and a growing emphasis on traceability and quality have made omega-3 ingredients integral to fish feed formulations, aligning with both consumer interests and sustainability goals.

    Get more detailed insights about EPA and DHA Omega-3 Ingredient Market

    Regional Insights

    The EPA and DHA Omega-3 Ingredient Market is projected to experience significant growth across various regional segments. In 2023, North America held a dominant position with a market valuation of 0.93 USD Billion, expected to rise to 1.404 USD Billion by 2032, showcasing its majority holding in the market. Europe follows closely, appreciating from 0.775 USD Billion to 1.248 USD Billion, indicating its significant demand driven by consumer awareness of health benefits. Meanwhile, the APAC region is expected to grow from 0.853 USD Billion to 1.482 USD Billion as increasing health consciousness and rising disposable income boost market consumption.

    South America, with a 2023 valuation of 0.543 USD Billion, is also anticipated to grow steadily to 0.780 USD Billion, reflecting increasing dietary supplement adoption. The MEA region, though least valued at 0.349 USD Billion in 2023, could see growth to 0.585 USD Billion, suggesting a gradual interest in omega-3 supplements. The distribution of values across these regions highlights varying levels of awareness, regulatory support, and consumer trends, contributing to the overall EPA and DHA Omega-3 Ingredient Market revenue.

    EPA and DHA Omega-3 Ingredient Market By Region

    Source Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The EPA and DHA Omega-3 Ingredient Market has gained significant traction in recent years, fueled by increasing awareness of the health benefits associated with omega-3 fatty acids. The competitive landscape of this market is characterized by a blend of established players and emerging companies that are striving to secure their positions through various strategies. These strategies include technological advancements, product diversification, and collaborative efforts in research and development to cater to the ever-evolving consumer demands.

    The push towards healthier dietary choices has prompted companies to innovate and expand their portfolios, aiming to fulfill the requirements of health-conscious consumers and leveraging the potential of omega-3 fatty acids in various applications such as dietary supplements, food and beverages, and pharmaceuticals. The competitive environment is marked by rigorous competition, regulatory challenges, and the need for sustainable sourcing of raw materials, further intricately shaping market dynamics and growth pathways.

    Cargill has established a prominent market presence within the EPA and DHA Omega-3 Ingredient Market, leveraging its extensive experience and resources in the food and nutrition sector. Cargill's strengths lie in its superior manufacturing capabilities, comprehensive supply chain integration, and commitment to sustainability, which resonate well with the growing consumer demand for ethically sourced ingredients. The company's robust research and development efforts enable it to innovate and produce high-quality omega-3 products that meet stringent regulatory standards and cater to diverse dietary needs.

    Additionally, Cargill's footprint allows it to effectively engage with a wide customer base, fostering strong relationships with clients across various sectors, including food and beverage, dietary supplements, and pet nutrition. This strategic positioning underpins Cargill's ability to maintain a competitive edge in the market and respond adeptly to emerging trends.

    Croda International is another key player in the EPA and DHA Omega-3 Ingredient Market, characterized by its focus on innovation and commitment to providing high-performance ingredients. Croda International's strengths are highlighted by its extensive research capabilities, which allow the company to develop specialized omega-3 solutions tailored to specific market needs. The company has a reputation for producing premium quality products, underscored by rigorous testing and compliance with international standards, thereby fostering trust and reliability among its customers. Furthermore, Croda International's sustainable sourcing practices and dedication to environmental stewardship enhance its appeal in a market increasingly influenced by eco-conscious consumers.

    With a well-established brand and a customer-centric approach, Croda International seeks to leverage its expertise in omega-3 ingredients to explore new opportunities and reinforce its position in the competitive landscape.

    Key Companies in the EPA and DHA Omega-3 Ingredient Market market include

    Industry Developments

    • Q2 2024: GC Rieber VivoMega opens new omega-3 production facility in Norway GC Rieber VivoMega inaugurated a new state-of-the-art omega-3 production facility in Kristiansund, Norway, expanding its capacity for high-concentration EPA and DHA ingredients to meet growing global demand.
    • Q1 2024: BASF launches new ultra-high purity EPA/DHA omega-3 ingredient for pharmaceuticals BASF announced the launch of a new pharmaceutical-grade EPA/DHA omega-3 ingredient, designed for use in prescription products targeting cardiovascular and inflammatory conditions.
    • Q3 2024: DSM-Firmenich partners with Evonik to scale sustainable algal omega-3 production DSM-Firmenich and Evonik entered a strategic partnership to expand the production of algal-based EPA and DHA omega-3 ingredients, aiming to supply both the nutraceutical and pharmaceutical sectors with sustainable alternatives to fish oil.
    • Q2 2024: Epax Norway AS appoints new CEO to drive global omega-3 expansion Epax Norway AS announced the appointment of a new Chief Executive Officer, citing plans to accelerate international growth and innovation in high-concentration EPA/DHA omega-3 ingredients.
    • Q1 2024: Clover Corporation secures major supply contract for DHA omega-3 with leading infant formula manufacturer Clover Corporation signed a multi-year supply agreement to provide DHA omega-3 ingredients to a top global infant formula producer, strengthening its position in the early life nutrition market.
    • Q3 2024: Solutex acquires microalgae facility to boost sustainable DHA production Solutex completed the acquisition of a microalgae production facility in Spain, enhancing its capacity to produce high-purity, plant-based DHA omega-3 ingredients for food and supplement applications.
    • Q2 2024: BASF receives regulatory approval for new omega-3 pharmaceutical in Japan BASF obtained regulatory clearance from Japanese authorities for its new prescription-grade EPA/DHA omega-3 product, enabling entry into the Japanese pharmaceutical market.
    • Q1 2024: Epax Norway AS launches next-generation high-potency EPA concentrate Epax Norway AS introduced a new high-potency EPA concentrate ingredient, targeting the cardiovascular health and clinical nutrition markets with improved purity and bioavailability.
    • Q2 2024: GC Rieber VivoMega signs partnership with US supplement brand for exclusive omega-3 supply GC Rieber VivoMega entered an exclusive supply agreement with a major US dietary supplement company to provide high-concentration EPA/DHA omega-3 oils for new product launches.
    • Q3 2024: DSM-Firmenich launches vegan omega-3 gummies with high DHA content DSM-Firmenich released a new line of vegan omega-3 gummies featuring high DHA content sourced from microalgae, targeting the growing plant-based supplement market.
    • Q2 2024: Croda International opens new omega-3 innovation center in the UK Croda International inaugurated a dedicated omega-3 innovation center in the United Kingdom, focusing on research and development of advanced EPA/DHA ingredients for functional foods and nutraceuticals.
    • Q1 2024: Clover Corporation receives regulatory approval for new DHA ingredient in China Clover Corporation secured regulatory approval from Chinese authorities for its latest DHA omega-3 ingredient, enabling expanded sales into the Chinese infant formula and supplement markets.

    Future Outlook

    EPA and DHA Omega-3 Ingredient Market Future Outlook

    The EPA and DHA Omega-3 Ingredient Market is projected to grow at a 5.33% CAGR from 2024 to 2035, driven by rising health awareness and demand for functional foods.

    New opportunities lie in:

    • Expansion into plant-based Omega-3 formulations
    • Development of personalized nutrition products
    • Strategic partnerships with food and beverage manufacturers

    By 2035, the market is expected to solidify its position as a leader in health-focused ingredients.

    Market Segmentation

    EPA and DHA Omega-3 Ingredient Market Form Outlook

    • Liquid
    • Softgel
    • Powder
    • Capsule
    • Emulsion

    EPA and DHA Omega-3 Ingredient Market Source Outlook

    • Fish Oil
    • Algal Oil
    • Krill Oil
    • Flaxseed Oil
    • Chia Seed Oil

    EPA and DHA Omega-3 Ingredient Market End-Use Outlook

    • Human Health
    • Pet Care
    • Aquaculture
    • Infant Formulas
    • Functional Foods

    EPA and DHA Omega-3 Ingredient Market Application Outlook

    • Nutraceuticals
    • Food & Beverages
    • Pharmaceuticals
    • Cosmetics
    • Animal Feed

    Report Scope

    MARKET SIZE 20243.821(USD Billion)
    MARKET SIZE 20254.025(USD Billion)
    MARKET SIZE 20356.767(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)5.33% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesGrowing consumer demand for plant-based EPA and DHA Omega-3 ingredients presents significant market opportunities.
    Key Market DynamicsRising consumer demand for sustainable sources drives innovation and competition in the EPA and DHA Omega-3 ingredient market.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Leave a Comment

    FAQs

    What is the expected market size of the EPA and DHA Omega-3 Ingredient Market in 2034?

    The market is expected to be valued at 6.42 billion USD in 2034.

    What is the projected CAGR for the EPA and DHA Omega-3 Ingredient Market from 2025 to 2034?

    The expected CAGR for the market during this period is 5.3%.

    Which region is anticipated to hold the largest market share in 2034?

    North America is expected to have the largest market share, valued at 1.404 billion USD in 2034.

    What are the expected market values for Fish Oil by 2034?

    The market value for Fish Oil is expected to reach 2.65 billion USD by 2034.

    What will be the market value of Algal Oil in 2034?

    The market value of Algal Oil is projected to reach 1.25 billion USD in 2034.

    Who are the key players in the EPA and DHA Omega-3 Ingredient Market?

    Major players include Cargill, DSM, BASF, and Aker BioMarine, among others.

    What is the expected market size for Krill Oil in 2034?

    The market size for Krill Oil is expected to be 0.8 billion USD in 2034.

    What is the market value for the APAC region in 2034?

    The APAC region is anticipated to reach a market value of 1.482 billion USD in 2034.

    What applications drive the demand for EPA and DHA Omega-3 ingredients?

    Applications include dietary supplements, functional foods, and pharmaceuticals.

    What is the expected market value for Chia Seed Oil in 2034?

    The market value for Chia Seed Oil is projected to be 0.25 billion USD in 2034.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions